MedPath

An interventional study to access the effect of Homoeopathic medicine Arsenicum album 30 C as a prohylaxis in high risk population exposed to COVID-19.

Phase 3
Registration Number
CTRI/2020/06/026056
Lead Sponsor
Ministry of AYUSH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Subjects of high risk population.

2. Male or female subjects above the age of 03 years to 65 years.

3. Subject who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study.

Exclusion Criteria

1. Pregnant and Lactating woman.

2. Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening.

3. Subjects who are on any other regular medication( Alternative/ Modern)for any other ailments.

4. Subjects participating in any other clinical study or having participated in any other study one month prior to screening in the present study.

5. Subjects having a past history of allergy to any medicine that is part of the Homoeopathic

intervention. Other conditions, which in the opinion of the investigators, makes the patient

unsuitable for enrolment or could interfere with his participation in, and completion of the protocol.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess of occurrence of COVID-19 infection in healthy volunteers exposed to COVID-19 in the communityTimepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
1. To assess the immunity status of the participants taking Arsenicum album -30 C <br/ ><br>2. To evaluate the occurance of advarse event for safety assessment of Arsenicum album-30C.Timepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath